Company Profile

PIRAMAL ENTERPRISES LTD.

NSE : PELBSE : 500302ISIN CODE : INE140A01024Industry : Pharmaceuticals & DrugsHouse : Piramal Ajay
BSE1386.70-36.45 (-2.56 % )
PREV CLOSE (Rs.) 1423.15
OPEN PRICE (Rs.) 1419.30
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 26390
TODAY'S LOW / HIGH (Rs.)1376.00 1442.00
52 WK LOW / HIGH (Rs.)608 1814.05
NSE1388.10 -35.65 (-2.5 % )
PREV CLOSE(Rs.) 1423.75
OPEN PRICE (Rs.) 1420.00
BID PRICE (QTY) 1388.10 (43 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 1734495
TODAY'S LOW / HIGH(Rs.) 1374.15 1442.00
52 WK LOW / HIGH (Rs.)606.85 1813.67

Smart Quotes

1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Trade Value (Rs. in Lacs) 0.00
Dividend Yield(%) 1.01
TTM EPS (Rs.) -14.26
P/E Ratio 0.00
Book Value (Rs.) 1001.74
Face Value (Rs.) 2
MCap (Rs. in Mn) 312753.95
Price/Earning (TTM) -209.33
Price/Sales (TTM) 8.34
Price/Book (MRQ) 1.38
PAT Margin (%) 3.43
ROCE (%) 6.41
Incorporation Year : 1947

Management Info :

Ajay Piramal - Chairman - Managing Director

Registered Office :

Address : Piramal Ananta Agastya Corporate Park ,Opposite Fire Brigade , Kamani Junction , L B S Marg ,Kurla ( W ),
Mumbai,
Maharashtra-400070

Phone : 022 3802 3000/4000

Website : www.piramal.com

Registrar's Details : Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE, MCX
NEWS More
20Nov11-20-2020$Piramal Enterprises informs about issuance of duplicate share certificate Piramal Enterprises informs

Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Piramal Enterprises has informed that the Registrar and Transfer Agent of the Company, Link Intime India has received request for issuance of duplicate share certificate from the shareholder, Vina Shailesh Limdi (Folio No: VR00605). The duplicate share certificate will be issued only after the receipt of all necessary documents from the Shareholder. Further details of the same as enclosed.

The above information is a part of company’s filings submitted to BSE.

Pursuant to Regulation 39(3) of the SEBI (Listing Obligations a..
30Oct10-30-2020$Piramal Enterprises jumps as its arm approves acquisition of CCPL from Navin Fluorine International Piramal Enterprises jumps as

Piramal Enterprises is currently trading at Rs. 1251.75, up by 36.50 points or 3.00% from its previous closing of Rs. 1215.25 on the BSE.

The scrip opened at Rs. 1228.55 and has touched a high and low of Rs. 1265.90 and Rs. 1223.50 respectively. So far 20065 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 1,829.02 on 07-Nov-2019 and a 52 week low of Rs. 608.00 on 24-Mar-2020.

Last one week high and low of the scrip stood at Rs. 1329.80 and Rs. 1198.90 respectively. The current market cap of the company is Rs. 28484.36 crore.

The promoters holding in the company stood at 46.06%, while Institutions and Non-Institutions held 39.13% and 14.81% respectively.

Piramal Enterprises’ subsidiary company -- Piramal Pharma (PPL) has approved the acquisition of additional 3,43,04,900 equity shares of the face value of Rs 10 each of Convergence Chemicals (CCPL) for an aggregate cash consideration of Rs 65.10 crore from Navin Fluorine International. Consequent to this Acquisition, CCPL would become a wholly owned subsidiary of PPL. The Acquisition is likely to be completed by January 31, 2021.

Piramal Enterprises is one of India’s large diversified companies, with a presence in Pharmaceuticals, Healthcare Information Management and Financial Services.

Piramal Enterprises is currently trading at Rs. 1251.75, up by..
29Oct10-29-2020$Piramal Enterprises’ arm approves acquisition of CCPL from Navin Fluorine International Piramal Enterprises’ arm a

Piramal Enterprises’ subsidiary company -- Piramal Pharma (PPL) has approved the acquisition of additional 3,43,04,900 equity shares of the face value of Rs 10 each of Convergence Chemicals (CCPL) for an aggregate cash consideration of Rs 65.10 crore from Navin Fluorine International. Consequent to this Acquisition, CCPL would become a wholly owned subsidiary of PPL. The Acquisition is likely to be completed by January 31, 2021.

Piramal Enterprises is one of India’s large diversified companies, with a presence in Pharmaceuticals, Healthcare Information Management and Financial Services.

Piramal Enterprises’ subsidiary company -- Piramal Pharma (PP..
07Oct10-07-2020$Piramal Enterprises’ arm completes 20% stake sale to Carlyle Group Piramal Enterprises’ arm c

Piramal Enterprises’ subsidiary -- Piramal Pharma has completed sale of 20 per cent stake for Rs 3,523.40 crore to US-based global investment firm Carlyle Group Inc. Piramal Pharma has received Rs 3,523.40 crore from CA Alchemy Investments, an affiliated entity of CAP V Mauritius, an investment fund managed and advised by affiliated entities of The Carlyle Group Inc.

The transaction values the Pharma Business at an enterprise value of $2,775 million (over Rs 20,300 crore) with an upside component of up to $360 million (over Rs 2,630 crore) depending on the company's FY21.

Piramal Enterprises is one of India’s large diversified companies, with a presence in Pharmaceuticals, Healthcare Information Management and Financial Services.

Piramal Enterprises’ subsidiary -- Piramal Pharma has complet..
07Oct10-07-2020$Piramal Enterprises informs about issuance of duplicate share certificates Piramal Enterprises informs
Piramal Enterprises has informed that the Registrar and Transfer Agent of the Company, Link Intime India has received request for issuance of duplicate share certificate from Abhishek Maddi with folio number 0034960, as under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.
Piramal Enterprises has informed that the Registrar and Transfe..
Financials More
Rs. in Millions
QTR Sep 20 ANNUAL 20
Net Profit1033.11448.5
Gross Profit 1212.4 5398.4
Operating Profit 5427.524253.6
Net Sales 10264.542191.9
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group More
Procter&Gamble Healt (BSE)
 6878.70 (8.26%)
M.Cap ( in Cr)
11418.22
Divis Lab (BSE)
 3607.60 (1.76%)
M.Cap ( in Cr)
95770.44
Ipca Laboratories (BSE)
 2196.85 (2.86%)
M.Cap ( in Cr)
27867.51
JB Chem & Pharma (BSE)
 994.25 (4.41%)
M.Cap ( in Cr)
7683.77
IOL Chem & Pharma (BSE)
 780.65 (5.02%)
M.Cap ( in Cr)
4582.85
Shareholding Pattern More
FI/BANKS/INSURANCE 8.7 %
PROMOTERS 46.06 %
NON-INSTITUTION 14.81 %
MUTUAL FUNDS/UTI 0.92 %
GOVERNMENT 0 %
FII 0 %
F & O Quotes